Timing of prophylactic implantable cardioverter-defibrillator implantation in patients with cardiomyopathy

首页> 外文期刊>The American Journal of Cardiology >Timing of prophylactic implantable cardioverter-defibrillator implantation in patients with cardiomyopathy

【24h】

Timing of prophylactic implantable cardioverter-defibrillator implantation in patients with cardiomyopathy

机译：心肌病患者预防性植入心肺除颤器 - 除颤器的定时

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The recent study by Zecchin et al is an important contribution to the debate regarding the appropriate timing of prophylactic implantable cardioverter-defi-brillator (ICD) implantation for patients with idiopathic dilated cardiomyopathy (DC). They have shown that with optimal medical therapy, 2/3 of patients with DC and "SCD-HeFT [Sudden Cardiac Death in Heart Failure] criteria" at presentation2 did not maintain ICD indications 3 to 9 months later. We wish to extend these observations by showing that even in patients with advanced heart failure and very low left ventricular ejection fractions (LVEFs), intensive medical management without ICD implantation can be associated with an exceptionally low 1-year mortality and, in many cases, with an improvement of the LVEF to >35%.

机译：Zechin等人最近的研究是对具有特发性扩张心肌病（DC）患者的预防性植入心脏病术（ICD）植入的适当定时对辩论的重要贡献。他们表明，随着最佳的医疗疗法，2/3的DC患者和“心力衰竭的SCD-HEFT [心力衰竭突然的心脏病患者]呈现2未在3至9个月后维持ICD适应症。我们希望通过表明，即使在晚期心力衰竭和左心室喷射分数（LVEFS）的患者中，没有ICD植入的密集医疗管理也可能与较低的1年死亡率有关，并且在许多情况下，改善LVEF至35％。

著录项

来源
《The American Journal of Cardiology》 |2012年第1期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Timing of prophylactic implantable cardioverter-defibrillator implantation in patients with cardiomyopathy [J] . The American Journal of Cardiology . 2012,第1期

机译：心肌病患者预防性植入心肺除颤器 - 除颤器的定时
2. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. [J] . Bhonsale A, James CA, Tichnell C, Journal of the American College of Cardiology . 2011,第14期

机译：对于有心律失常性右室发育不良/心肌病的患者，进行植入式心脏复律除颤器植入作为一级预防措施时，植入式心脏复律除颤器治疗的发生率和预测指标。
3. Prophylactic use of the implantable cardioverter-defibrillator and its effect on the long-term survival, cardiovascular and sudden cardiac death in nonischemic cardiomyopathy patients-a systematic review and meta-analysis [J] . Siddiqui Waqas Javed, Aggarwal Sandeep, Rafique Muhammad, Heart failure reviews . 2018,第2期

机译：预防植入心脏除颤器的预防用途及其对非缺血性心肌病患者的长期存活，心血管和心脏死亡的影响 - 系统审查和荟萃分析
4. No News is Good News: Remote Monitoring of Implantable Cardioverter-Defibrillator Patients [C] . Mikael B. Skov, Pauline G. Johansen, Charlotte S. Skov, Annual CHI Conferenceon Human Factors in Computing Systems . 2015

机译：没有新闻是好消息：远程监控植入式心脏病 - 除颤器患者
5. Incidence and clinical predictors of risk factors for inappropriate shock in patients with implantable cardioverter-defibrillators [D] . Lo, Shu-Ling 2005

机译：植入式心脏复律除颤器患者不适当电击危险因素的发生率和临床预测因素
6. Prophylactic catheter ablation of ventricular tachycardia before cardioverter-defibrillator implantation in patients with non-ischemic cardiomyopathy: Clinical outcomes after a single endocardial ablation [O] . Atsushi Suzuki, Akihiro Yoshida, Asumi Takei, 1998

机译：非缺血性心肌病患者在心脏复律除颤器植入前预防性室速的导管消融：单次心内膜消融后的临床结果
7. How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with “SCD-HeFT Criteria?” MassimoZecchinMarcoMerloAlbertoPivettaGiuliaBarbatiCristinaLutmanDarioGregoriLaura VitaliSerdozStefanoBardariSilviaMagnaniAndreaDi LenardaAlessandroProclemerGianfrancoSinagraHow can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with “SCD-HeFT Criteria?”Am. J. Cardiol.1092012729735 [O] . Khanal Suraj 2013

机译：对于具有“ SCD-HeFT标准”的特发性扩张型心肌病患者，如何优化药物治疗才能避免不必要的可植入式心脏复律除颤器植入？ MassimoZecchinMarcoMerloAlbertoPivettaGiuliaBarbatiCristinaLutmanDarioGregoriLaura VitaliSerdozStefanoBardariSilviaMagnaniAndreaDi LenardaAlessandroProclemerGianfrancoSinagra如何优化药物治疗，避免伴有植入性心脏起搏器-心电除颤的CDFT植入式心脏除颤器患者的不必要的可植入心脏复律性心脏除颤术？卡迪尔.1092012729735

Timing of prophylactic implantable cardioverter-defibrillator implantation in patients with cardiomyopathy

摘要

著录项

相似文献

相关主题

期刊订阅